• 0 (+212) 661 74 88 62
  • lvobeen.oncoviruses5@gmail.com
  • FSTM, Mohammedia, Morocco
  • 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds

Laboratory of Virology, Oncology, Biosciences, Environment and New Energies
Faculty of Sciences and Techniques Mohammedia University Hassan II of Casablanca
and international & national collaborators

Organize

The Fifth International
Symposium on Emergent & Remergent
Viral Pathogens

Theme : Oncoviruses, Cancers, and Biotechnologies: Artificial Intelligence at the Service of Socio-Economic Challenges for Sustainable Health, Environment, and Economy

Symposium Venue
Faculty of Sciences and Techniques Mohammedia

DECEMBER, 19, 20 AND 21, 2024

Symposium Chairman
Pr. Dr. Moulay Mustapha Ennaji M.Sc, Ph.D, RSM(CCM)
Head of Laboratory Of Virology, Oncology, Biosciences, Environment And New Energies (LVO BEEN)
Group leader research team of Virology, Oncology & Biotechnology

Coordination & Contacts

Personal:

+212 661 74 88 62

+212 662 01 37 72

Email:

m.ennaji@yahoo.fr

my.mustaphaennaji@univh2mc.ma

my.mustaphaennaji@fstm.ma

Symposium Information:

https://www.fstm-fisvc.com

lvobeen.oncoviruses5@gmail.com

5th Symposium on Emerging and Re-emerging Pathogens “Theme: Oncoviruses, Cancers, and Biotechnology: Socio-economic Challenges for Sustainable Health, Environment, and Economy”

Argument

Oncoviruses, the infectious agents behind several cancer types, along with the integration of artificial intelligence (AI) within emerging biotechnologies, present complex socio-economic challenges that affect public health, environmental sustainability, and economic development. These challenges are particularly pronounced in Morocco and comparable middle-income countries. This symposium aims to establish a multidisciplinary platform exploring the transformative potential of AI-driven biotechnological innovations in addressing cancers associated with oncoviruses. The event will not only examine the unique challenges and opportunities within the Moroccan context but will also place them within an interconnected global perspective to uncover synergies and partnerships that may bridge existing technological gaps.
In Morocco, cancers associated with oncoviruses—such as cervical cancer linked to the human papillomavirus (HPV) and hepatocellular carcinoma associated with the hepatitis B virus—are placing an increasing strain on the healthcare system. The country has made strides in implementing vaccination campaigns, such as the rollout of the HPV vaccine, aimed at reducing these burdens.
However, these efforts face multiple challenges, including pronounced regional disparities in healthcare access, limited medical infrastructure in rural areas, and insufficient public awareness. In this context, AI presents significant potential to optimize the healthcare system, from early detection of viral cancers to enhancing outreach and education efforts.
Yet, the successful adoption of AI-enhanced biotechnologies requires overcoming several local barriers. Funding constraints, a nascent research infrastructure, and a lack of specialized training currently limit Morocco’s ability to capitalize on these technologies. This symposium will delve into these systemic obstacles, examining national policies and funding strategies designed to improve oncovirus-related cancer prevention and to stimulate growth in Morocco’s biotechnology sector.
AI-driven predictive analytics, telemedicine, and personalized medicine could serve as critical tools, and the symposium will address how they can be adapted and implemented within the constraints of Morocco’s healthcare landscape. On a global scale, advancements in biotechnology, particularly those augmented by AI, have led to groundbreaking progress in diagnosing, treating, and preventing viral cancers. Cutting-edge solutions such as gene therapies, therapeutic vaccines, and genome editing are now reshaping traditional approaches to oncology, allowing for more personalized and effective treatments.
However, these innovations often come with high costs, creating accessibility issues, particularly for middle-income countries like Morocco. The rapid expansion of the biotechnology and AI sectors is predominantly concentrated in economically powerful regions, which risks leaving Morocco on the periphery of these technological advancements.

In response, this symposium will highlight potential pathways for international collaboration, technology transfer, and knowledge-sharing initiatives to help integrate Morocco into the global AI-biotechnology landscape. By fostering partnerships with leading international institutions and private sector stakeholders, Morocco could gain access to necessary technologies and expertise.
Furthermore, AI’s role in accelerating these innovations will be explored, such as its potential to streamline research processes, reduce costs, and enhance precision in diagnosis and treatment, making advanced biotechnologies more attainable. The effects of these AI-enhanced biotechnologies extend beyond healthcare, raising crucial environmental and economic concerns. Large-scale production processes for biomedicines, along with novel cell culture methods and genetic manipulation techniques, impact local ecosystems, especially in terms of biomedical waste management. Morocco must consider how to handle increased volumes of waste from biotechnology research and production, ensuring sustainable practices that do not compromise environmental integrity. AI technologies can contribute by developing optimized waste management solutions, tracking ecological impacts, and predicting potential risks associated with biotechnological production processes.
From an economic standpoint, the development of a robust AI-driven biotechnology sector necessitates a strategic shift in industrial policy. Morocco must focus on nurturing local expertise through specialized training and fostering an environment that attracts foreign investment. Building a national biotechnology industry, particularly one integrated with AI advancements, requires investment not only in physical infrastructure but also in human capital.
This symposium will address the strategies needed to develop a skilled workforce capable of driving Morocco’s biotechnology and AI sectors, thus creating a sustainable economic model that promotes innovation and reduces dependence on imported technologies.
This symposium will bring together Moroccan and international experts across fields including virology, oncology, health, biotechnology, artificial intelligence, economics, and environmental science.
By fostering interdisciplinary discussions, the symposium aims to provide a holistic understanding of the multifaceted challenges posed by oncoviruses and AI-enhanced biotechnologies. Attendees will have the opportunity to explore how AI can serve as a pivotal tool in tackling these challenges by enhancing precision in healthcare, enabling data-driven policy-making, and offering sustainable economic solutions.
The objective is to propose actionable solutions that strengthen Morocco’s local capacities in addressing oncovirus-related cancers while addressing broader global issues of environmental sustainability and economic inclusivity in the AI-biotechnology sector. This event aspires to catalyze innovation, encourage policy reform, and stimulate international partnerships, ensuring that Morocco can actively participate in and benefit from the dynamic and rapidly evolving landscape of AI and biotechnology

Symposium Research Axes

AxisI: HPV, Gynecological Cancers, Prevalence, Diagnostics, Vaccination, and Co-Infections.
Axis II: New Approaches for Diagnosing Oncoviruses and Cancer
Axis III: EBV, Papillomavirus, and Viral Hepatocarcinoma
Axis IV: Other Oncogenic Viruses and Cancers
Axis V: Other Pathological Diseases
Axis VI: Biotechnology and Health
Axis VII: Biotechnology and Environment
Axis VIII: Biotechnology for Economic Development
Axis IX: Viruses and Nanotechnology
Axis X: Artificial Intelligence in Biotechnology
Axis XI: Tumor and Viral Biomarkers (microRNAs)
Axis XII: Quality
Axis XIII: health and the environment

Participation and Collaboration

The success of this event relies on the commitment of all stakeholders, including governments, the private sector, academic institutions, and non-governmental organizations. Diverse participation is therefore essential to make this symposium a true catalyst for progress, aimed at strengthening efforts against oncoviruses and promoting sustainable, accessible biotechnological solutions. We warmly invite all stakeholders to join us in this crucial initiative, to collaborate and share knowledge and resources to tackle global health challenges related to viral cancers. Together, we can create a healthier and more sustainable future for current and future generations, both in Morocco and beyond.

To participate in the Fifth Symposium on Emerging and Re-emerging Pathogens, researchers and professionals are invited to submit their abstracts according to the timeline outlined below. Submissions must be sent via the official event email, allowing participants to upload their documents and follow the review process.

Submission of Contributions

Submission Timeline and Key Dates

October 30: Call for abstracts opens. Interested participants may begin submitting their abstracts online.
November 30: Abstract submission deadline. No submissions will be accepted after this date.
December 02: Abstract acceptance notifications. Authors will be informed whether their proposals have been accepted or rejected.
December 05: Deadline for symposium participation fee payment and submission of confirmation to the registration committee.
December 19, 20, and 21, 2024: the fifth Symposium on Emerging and Re-emerging Pathogens.

Scientific committee

National :

Pr.Moulay Mustapha Ennaji, Morocco
Pr.Chakor Abdellatif, Morocco
Pr.Attouch Hicham, Morocco
Pr.Chegri Bader Eddine, Morocco
Pr.Bennani Abdelouahab, Morocco
Pr.Amine Abdessamad, Morocco
Pr.Barakat Mustapha, Morocco
Pr.Bessi Hlima, Morocco
Pr.Bouziyane Amal, Morocco
Pr.Hafid Jamal Eddine, Morocco
Pr.Himmi Benacer, Morocco
Pr.Lakhiari Hamid, Morocco
Pr.Kettani Halabi Mohamed, Morocco
Pr.Laraqui Abdelilah, Morocco
Pr.Lkhider Mustapha, Morocco
Pr.El mzibri Mohamed, Morocco
Pr. Baha Warda, Morocco
Pr.Boughribil Said, Morocco
Pr.Benchekroun Mohammed Nabil, Morocco
Pr.Ahnyne Redouane, Morocco
Pr.Boussettine Rihab, Morocco
Pr.El bakirdi Zakaria, Morocco
Pr.Hassou Najwa, Morocco
Pr.Rahhal Rachid, Morocco
Pr.Ghosne Nadia, Morocco

Pr.Abouabdellah Yassir, Maroc
Pr. Mouallif Mustapha, Morocco
Pr.Ouedghiri Mouna , Morocco
Pr.Sayeh Ezzikouri , Morocco
Pr.Takati Nadia, Morocco
Pr.Ennibi Khalid, Morocco
Pr.Tagajdid Rida, Morocco
Pr.Abbi Rachid, Morocco
Pr.Naitlhou Abdelhamid, Morocco
Pr.Bennani Bahia, Morocco
Pr. Berehou Amine, Morocco
Pr.Amghar Souad, Morocco
Pr.Benjouad Abdelaziz, Morocco
Pr.Saile Rachid , Morocco
Pr.Attaleb Mohammed , Morocco
Dr.Azmi Hasna, Morocco
Pr.Aboudkhil Souad, Morocco
Pr.Qmichou Zineb, Morocco
Pr.Souiri Amal, Morocco
Pr.Lemriss Sanaa , Morocco
Pr.Abdelghafar Houria, Morocco
Pr.Bennani Mechita Mohcine, Morocco
Pr.Zyad Abdelmajid, Morocco
Pr. Berradi Hind, Morocco

International :

Anicet Bomba, Congo
Berjas Abumsimir, Jurdan
Donatien Moukassa, Congo
Etienne Mokonfjimobe, Congo
Guorong Li, France
Ihsane Ali Mhasneh, UAE
Jean-Rosaire Ibara, Congo
Longo Mbenza, Democratic Republic Of The Congo

Karomoko Yahya, Côte d’Ivoire
Mokondzi Mobe, Congo
Samira Zoa, Gabon
Bourlet Thomas, France
Yassin Kasmi, Germany
Angélique Ndjoyi, Gabon
Črtomir Podlipnik, Slovenia

International Steering Committee :

Bourlet Thomas, France
Hafid Jamal Eddine, Morocco

Jalid Sehouli, Germany
Ennaji Moulay Mustapha, Morocco

Organizing Committee:

Ennaji Moulay Mustapha
Bennani Abdelouahab
Barakate Mustapha
Benchekroun Mohammed Nabil
Benhessou Mustapha
Bessi Hlima
Had Jamal Eddine
Amal SAFI
Mohamed Kettani Halabi
Lamsisi Maryame
Laraqui Abdelilah
Lkhider Mustapha
El mzibri Mohamed
Lakhiari Hamid
Mouallif Mustapha
Ahnyne Redouane
Boussettine Rihab
El bakirdi Zakaria
Souad Tayane
Berradi Hind

Hassou Najwa
Rahhal Rachid
Naseh Malika
Chtaibi Amine
Sayeh Ezzikouri
Takati Nadia
Bennani Bahia
Amghar Souad
Boutaleb Nadia
Khatabi Khadija
Boughribil Said
Bahlaouan Bouchaib
Zyad Abdelmajid
Rihane Fatima Ezzahra
Azmi Hasna
Anouar Tadlaoui Kaoutar
Bourlet Thomas
Akbour Houda Mohamed Nemiche

Doctoral Support Committee:

Ennaji Youssef/Alaoui Sosse Soukayna/ Tiabi Ikram/ Aqerrout Mouna/ Mharrach Imane/ Abulalaa Kawtar/ Dorine Florence Luthera Ngombe Mouabata / Morjani Ouafaa /Mahari Imane / Nabil Said Abdellah/ Nabil Kawtar / Najih Mouad /Patrina Joseph Iloukou Mayakia/ Benrkia Rachid/ Sakhi Zineb.

Master MAGBIO 2024 :

• Radi Salma
• Zahra Sidid
• Dounia Richi
• Oussaadi Imane
• Nassima sadik

Master MQSA 2024 :

• EL aouame Kenza
• Chokrri Maroua
• Ettahiry Khadija
• EL hodaigu Zineb
• Boukdair Meryem
• Alaziz Zainab

National (Public and Private), Regional, and International Partners:

• Ministry of Health and Social Protection
• Higher Institute of Nursing and Health Technology, Rabat
• Faculty of Medicine, Jean Monnet University, Saint-Étienne, France
• Faculty of Science and Technology, Gueliz, Cadi Ayyad University, Marrakech
• Charité Virchow University Hospital, Berlin, Germany
• Faculty of Allied Medical Sciences, Al-Ahliyya University, Amman, Jordan
• Faculty of Science, University of Sharjah, United Arab Emirates
• Pasteur Institute of Casablanca, Morocco
• Mohammed V Military Hospital, Rabat, Morocco
• Others...

Additional Benefits :

By participating in this event, you will have the opportunity to:
• Meet and engage with policymakers, researchers, investors, healthcare professionals, and academic experts specializing in oncoviruses and biotechnology
• Take part in enriching discussions on critical issues for developing sustainable and innovative health solutions in Morocco and internationally
• Access public-private partnership opportunities to strengthen research and intervention capacities in the health sector
• Contribute to promoting strategic investments in health infrastructure, enhancing accessibility and improving the quality of care
• Participate in sessions dedicated to human capital development and specialized skill-building in health and biotechnology
• Benefit from close collaboration and knowledge-sharing with a diverse network of stakeholders committed to tackling emerging pathogens and advancing biotechnology
Your participation will position you at the forefront of advances and transformational initiatives in the healthcare sector.

Symposium Chairman:

Pr.Ennaji Moulay Mustapha

lvobeen.oncoviruses5@gmail.com

  • Location

    FST Mohammedia, Morocco

  • Mobile Phone

    0 (+212) 661 74 88 62

  • Email

    lvobeen.oncoviruses5@gmail.com